Hepatocellular carcinoma (HCC) is an aggressive primary liver malignancy often diagnosed at an advanced stage, resulting in a poor prognosis. Accurate risk stratification and early detection of HCC are critical unmet needs for improving outcomes. Several blood-based biomarkers and imaging tests are available for early detection, prediction, and monitoring of HCC. However, serum protein biomarkers such as alpha-fetoprotein have shown relatively low sensitivity, leading to inaccurate performance. Imaging studies also face limitations related to suboptimal accuracy, high cost, and limited implementation. Recently, liquid biopsy techniques have gained attention for addressing these unmet needs. Liquid biopsy is non-invasive and provides more objective readouts, requiring less reliance on healthcare professional’s skills compared to imaging. Circulating tumor cells, cell-free DNA, and extracellular vesicles are targeted in liquid biopsies as novel biomarkers for HCC. Despite their potential, there are debates regarding the role of these novel biomarkers in the HCC care continuum. This review article aims to discuss the technical challenges, recent technical advancements, advantages and disadvantages of these liquid biopsies, as well as their current clinical application and future directions of liquid biopsy in HCC.
Citations
Citations to this article as recorded by
Therapeutic effects of the n-butanol extract of Potentilla freyniana Bornm. in hepatocellular carcinoma cells Yan Wang, Zaiqi Zhang, Liang Cao, Sisi Huang, Xi Huang, Ziyang Zhang, Yanbin Zhang, Xiang Li Journal of Ethnopharmacology.2026; 354: 120492. CrossRef
Liver cancer stem cells as novel diagnostic biomarkers Qamar Abuhassan, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, Soumya V. Menon, Priya Priyadarshini Nayak, J. Bethanney Janney, Vimal Arora, Aashna Sinha, Hayder Naji Sameer, Atheer Khdyair Hamad, Zainab H. Athab, Mohaned Adil Clinica Chimica Acta.2026; 580: 120739. CrossRef
Clinical utilization of testing for cell-free DNA in hepatocellular cancer Jasmine J. Wang, Yi-Te Lee, Amy K. Kim, Augusto Villanueva, Amit G. Singal, Ju Dong Yang Hepatology.2026;[Epub] CrossRef
Targeting copper death-related long non-coding RNAs: a novel strategy to overcome immunotherapy resistance in liver cancer Xiyang Sheng, Chen Mi, Gengyuan Shi, Longbo Wang, Yongzhao Li, Dongdong Wang, Wei Wang, Yongyue Du, Siyang Wang, Hanteng Yang Frontiers in Immunology.2026;[Epub] CrossRef
Synergistic role of multi-omics analysis combined with multimodal imaging in precision diagnosis and treatment of thoracic and abdominal tumors Bin Su, Junshan Li, Jie Zhang, Tao Deng, Zheng Fang, Yuanlong Wang Current Radiopharmaceuticals.2026; 19(3): 100040. CrossRef
Artificial intelligence-powered liquid biopsy in cancer: a paradigm shift in cancer detection and personalized care Sherihan G. AbdelHamid, Esraa M. Halawa, Eman M. Ibrahim, Mahmoud ElHefnawi Cancer Cell International.2026;[Epub] CrossRef
Plasma exosome-derived tsRNAs as a novel noninvasive biomarker for early detection and prognosis prediction of hepatocellular carcinoma Lin Ding, Yini Li, Te Liu, Xinyi He, Ying Zhao, Baishen Pan, Wenjing Yang, Xinrong Yang, Wei Guo, Beili Wang Genes & Diseases.2026; : 102180. CrossRef
Exploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinoma Charmi Jyotishi, Suresh Prajapati, Mansi Patel, Reeshu Gupta Journal of Liver Cancer.2026; 26(1): 104. CrossRef
Liquid biopsy: Fundamental principles and clinical value in hepatocellular carcinoma Anil Chandra Anand, Dibyalochan Praharaj, Preetam Nath Journal of Integrative Medicine and Research.2025; 3(3): 148. CrossRef
Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma Ahmet Gökhan Sarıtaş, Burak Yavuz, İshak Aydın, Harun Ağca, Uğur Topal, Tuğsan Ballı, Atil Bisgin, Abdullah Ülkü, Atılgan Tolga Akçam Journal of Hepatocellular Carcinoma.2025; Volume 12: 2035. CrossRef
Electrochemical Biosensor Based on a Tetrahedral DNA Nanostructure and an “AND” Logic Gate-Regulated Cascade Amplification System for Parallel Detection of Dual Disease Biomarkers Li Yang, Ya Zhou, Huimin Li, Yao Gao, Xiaoli Xiong, Tao Zhang, Liping Zhu, Xiurong Yang ACS Sensors.2025; 10(10): 7744. CrossRef
Machine Learning-based Gene Biomarker Identification for Improving Prognosis and Therapy in Hepatocellular Carcinoma Lingyan Deng, Lei Dou, Xinyu Huang, Peng Wang, Na Shen Current Medicinal Chemistry.2025; 32(39): 8975. CrossRef
Preclinical Studies on the Photothermal Therapy of NIR‐II AIEgens: Across Tumor Types Zijuan Meng, Xiaohua Ji, Shengyan Yin, Zhen Zhang, Ruihua Dong, Zheng Zhao, Ben Zhong Tang Small.2025;[Epub] CrossRef
Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration Nasar Alwahaibi, Maryam Alwahaibi Frontiers in Medicine.2025;[Epub] CrossRef
Liver cancer remains a challenge of global health, being the 4th leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and is usually precipitated by chronic viral infections (hepatitis B and C), non-alcoholic steatohepatitis, heavy alcohol use, and other factors which may lead to chronic inflammation and cirrhosis of the liver. There have been significant advances in the systemic treatment options for HCC over the past decades, with several approvals of both immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with preserved liver function. These advances have led to improvement in survival outcomes, with expected survival of greater than 18 months, in those with sensitive tumors, adequate liver function, and those functionally fit to receive sequential therapies. Several ongoing and promising trials are now evaluating combinational strategies with novel systemic agents and combinations of systemic therapy with locoregional therapy. In view of these trials, further advances in the treatment of HCC are foreseen in the near future.
Citations
Citations to this article as recorded by
Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Soo Young Hwang, Mohammad Saeid Rezaee-Zavareh, Abdelrahman M. Attia, Emily A. Kaymen, Nguyen Tran, Ghassan K. Abou-Alfa, Neehar D. Parikh, Amit G. Singal, Ju Dong Yang American Journal of Gastroenterology.2026; 121(2): 383. CrossRef
A comprehensive review of targeting early-stage biomarkers by small molecules and phytochemicals in hepatocellular carcinoma Suryaa Manoharan, Ilakkiya Govindaraju, Viswaganesh Venkatesan, Ekambaram Perumal Phytochemistry Reviews.2026; 25(1): 1323. CrossRef
Response Assessment in Hepatocellular Carcinoma: A Primer for Radiologists Nayla Mroueh, Jinjin Cao, Shravya Srinivas Rao, Soumyadeep Ghosh, Ok Kyu Song, Sasiprang Kongboonvijit, Anuradha Shenoy-Bhangle, Avinash Kambadakone Journal of Computer Assisted Tomography.2026; 50(2): 167. CrossRef
Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients: Correspondence to letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study” Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu Clinical and Molecular Hepatology.2026; 32(1): e99. CrossRef
Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study” Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming-Lung Yu Clinical and Molecular Hepatology.2026; 32(1): e68. CrossRef
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Diagnostic and Interventional Imaging.2026; 107(1): 25. CrossRef
SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells Wufei Ye, Tao Chen, Yueran Li, Jiajie Luan, Kui Yang, Sheng Wang Acta Biochimica et Biophysica Sinica.2026;[Epub] CrossRef
Celastrol delays the progression of hepatocellular carcinoma by suppressing SLC1A5-mediated glutamine dependence Simeng Xiao, Yun Zhao, Zhiguo Chen, Yangkun Xiong, Dingmei Zhang, Gang Zhou, Cong Zhang Toxicology and Applied Pharmacology.2026; 507: 117690. CrossRef
Discovery of novel small molecule inhibitor targeting the tumor promoting effect of transcription factor PLAGL2 Yushi Ding, Zhi Wang, Xingyu Xia, Jiayi Wang, Zhenyu Li, Congying Gu, Chenyan Hao, Kang Xu, Mengkang Gao, Hao Yin, Siheng Chen, Xin Gong, Wang Zhou, Min Zhang, Yong Yang, Dayong Zhang, Beiying Dai, Menghan Zhang European Journal of Medicinal Chemistry.2026; 303: 118471. CrossRef
Artificial Intelligence Applications in the Diagnosis, Treatment, and Prognosis of Hepatocellular Carcinoma Ming-Ying Lu, Jacky Chung-Hao Wu, Henry Horng-Shing Lu, Mohammed Eslam, Ming-Lung Yu Gut and Liver.2026; 20(1): 5. CrossRef
A Tumor-Activatable Sorafenib Prodrug for Alleviating Hypoxia and Enhancing Hepatocellular Carcinoma Therapy Xinhao Zhang, Jialin Kuang, Na Li, Wei Pan, Bo Tang ACS Materials Letters.2026; 8(2): 517. CrossRef
Injectable hyaluronic acid-based hydrogels with carbon dots and an iron complex for embolization Minyoung Jin, Sanghee Lee, Yuhyeon Na, Hayoon Jeong, Dong-Hyun Kim, Kun Na Materials Horizons.2026; 13(7): 3474. CrossRef
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial Hyunjae Shin, Youngsu Park, Byeong Geun Song, Won-Mook Choi, Hyung Joon Han, Youngwoo Lee, Tae-Jin Song, Jong-Eun Yeon, Young-Suk Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon, Jeong-Hoon Lee Cancer Immunology, Immunotherapy.2026;[Epub] CrossRef
Hydroxy Safflower Yellow A: A Natural Compound from Carthamus tinctorius L. with Potent Activity Against Liver Fibrosis and Cancer Yuyan Yang, Lvchen He, Wenfei Yang, Yujing Feng, Ruping Li, Yanxin Wu, Ruotong Yang, Wenjuan Xiao, Yao He Phytomedicine.2026; 153: 157858. CrossRef
Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi Clinical and Molecular Hepatology.2026; 32(1): e38. CrossRef
Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approach Sun Young Yim, Hayeon Kim, Tae Hyung Kim, Sang-Hee Kang, Youngwoo Lee, Eunho Choi, Yang Jae Yoo, Seong Hee Kang, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kyung Suk Yang, Yitao Tang, Bowha Sohn, Yun Seong Jeong, Hyewon P JHEP Reports.2026; 8(4): 101742. CrossRef
Association between peripheral IFN-γ+ cytotoxic lymphocytes and response to PD-1/PD-L1-based therapy in hepatocellular carcinoma Hui Lu, Huijuan Fang, Mengqi Ruan, Zhi Duang, Yan Wang, Wenwen Liu, Qin Wang, Qiang Zhou Frontiers in Immunology.2026;[Epub] CrossRef
Poor prognostic factors in patients with intrahepatic cholangiocarcinoma undergoing anatomic hepatectomy Haisu Wang, Qingxiang Xu Asian Journal of Surgery.2026;[Epub] CrossRef
Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting Zhao Ruan, Xuedan Sun Hepatoma Research.2026;[Epub] CrossRef
The NPC1/USP7/p53 axis regulates cholesterol and promotes the proliferation of hepatocellular carcinoma Ru Deng, Xiaoming Zheng, Feihong Liu, Jing Gao, Shubin Wang, Jingping Yun, Feng Wang, Ying Li, Xixiong Ai, Yajie Liu Oncogene.2026; 45(15): 1386. CrossRef
Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective? Hee Sun Cho, Soon Kyu Lee International Journal of Molecular Sciences.2026; 27(6): 2680. CrossRef
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma Yun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim, Bo Hwa Sohn, Sun Young Yim, Ji Hoon Kim, Jae Jun Shim, Sung Hwan Lee, Yun Shin Chun, Sunyoung S. Lee, Hui Dai, Ahmed Kaseb, Koo Jeong Kang, Holger K. Eltzschig, A. Robert MacLeod, Xiaolin Luo, Alexey Revenko, You Cancer Communications.2026;[Epub] CrossRef
Identification of a novel platelet-related prognostic model for hepatocellular carcinoma Hong Pan, Xi Cheng, Yong Dong, Da Li Discover Oncology.2026;[Epub] CrossRef
The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome Soon Kyu Lee, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon, Eun Sun Jung, Jong Young Choi Transplantation.2025; 109(5): 784. CrossRef
The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies Shuairan Zhang, Hang Dong, Xiuli Jin, Jing Sun, Yiling Li Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167676. CrossRef
Organoids and spheroids: advanced in vitro models for liver cancer research Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial” Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee Clinical and Molecular Hepatology.2025; 31(1): e84. CrossRef
Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL” Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian Clinical and Molecular Hepatology.2025; 31(1): e58. CrossRef
Artificial intelligence-assisted platform performs high detection ability of hepatocellular carcinoma in CT images: an external clinical validation study Rongxue Shan, Chenhao Pei, Qianrui Fan, Junchuan Liu, Dawei Wang, Shifeng Yang, Ximing Wang BMC Cancer.2025;[Epub] CrossRef
Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis” Moon Haeng Hur, Yoon Jun Kim Clinical and Molecular Hepatology.2025; 31(1): e93. CrossRef
SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1/SQLE pathway Hua Xiao, Zhaoying Yao, Tao Li, Xin Fang, Xuejiao Xu, Sheng Hu, Ya Yang, Chenchen Jin, Yuxiang Fei, Chao Liu, Qianming Du International Immunopharmacology.2025; 150: 114259. CrossRef
Celecoxib as a potential treatment for hepatocellular carcinoma in populations exposed to high PFAS levels Boshi Sun, Yuqiao Zhao, Shifeng Yang, Xiaodong Li, Nana Li, Yujie Wang, Qixiang Han, Xuyun Liu, Qiushi Tu, Jie Zheng, Xinyu Zhang Journal of Hazardous Materials.2025; 489: 137613. CrossRef
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis Changcheng Tao, Liguo Liu, Nan Hu, Hongwei Wang, Kai Zhang, Yue Liu, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu Journal of Hepatocellular Carcinoma.2025; Volume 12: 261. CrossRef
Exosome biosensors for detection of liver cancer Asma Vafadar, Mohammad Younesi, Sepideh Babadi, Mehdi Alizadeh, Ahmad Movahedpour, Amir Savardashtaki Clinica Chimica Acta.2025; 570: 120199. CrossRef
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges Theodoros Pettas, Sofia Lachanoudi, Filippos F Karageorgos, Ioannis A Ziogas, Asimina Fylaktou, Vassilios Papalois, Georgios Katsanos, Nikolaos Antoniadis, Georgios Tsoulfas World Journal of Transplantation.2025;[Epub] CrossRef
Management strategies for advanced hepatocellular carcinoma with
portal vein tumor thrombosis Jeayeon Park, Su Jong Yu The Ewha Medical Journal.2025;[Epub] CrossRef
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2025; 31(Suppl): S228. CrossRef
Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma Minchun Chen, Jing Shen, Rongrong Jia, Mingze Chang, Jingyi Zhang, Jie Zheng, Runqing Xue, Lulu Guo, Kangkang Yan Frontiers in Pharmacology.2025;[Epub] CrossRef
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis Jinxiang Peng, Haozhu Chen, Zhuang Chen, Jinmei Tan, Feng Wu, Xiaojuan Li BMC Cancer.2025;[Epub] CrossRef
Management of hepatocellular carcinoma in elderly and adolescent/young adult populations Han Ah Lee Journal of Liver Cancer.2025; 25(1): 52. CrossRef
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model Yi-Fan Li, Lan-Qing Yao, Chao Li, Hong Ren, Jin-Bo Gong, Han Wu, Li-Hui Gu, Ying-Jian Liang, Yu-Ze Yang, Kong-Ying Lin, Zi-Qiang Li, Qi-Xuan Zheng, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Hong-Wei Guo, Jia-Hao Xu, Zhong Chen, Feng Shen, Ming-Da Wang, Tian Annals of Surgical Oncology.2025; 32(6): 4396. CrossRef
Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025 Khalil I Alshammari, Ibrahim Ginawi, Hisham Sherfi, Hussain G Ahmed Cureus.2025;[Epub] CrossRef
Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma Kaiming He, Desheng Chen, Dongzi Zhu, Wenjie Zheng, Lei Lyu, Mingshen Zhang, Zeping Chen, Xiaowen Wang, Yongwei Hu, Binsheng Fu Journal of Nanobiotechnology.2025;[Epub] CrossRef
Application of LI-RADS CT/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma Jaeseung Shin, Sunyoung Lee, Ja Kyung Yoon, Kyowon Gu, Sun-Young Baek, Dong-Ho Hyun, Gyoung Min Kim, Jong Yun Won Japanese Journal of Radiology.2025; 43(9): 1498. CrossRef
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng Frontiers in Immunology.2025;[Epub] CrossRef
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma Jipin Li, Tao Yong, Yali Chen, Tingyu Zeng, Kaifeng Zhang, Shuping Wang, Youcheng Zhang Frontiers in Pharmacology.2025;[Epub] CrossRef
B-cell receptor repertoire signature as a diagnostic biomarker for hepatocellular carcinoma Zixue Xuan, Qiang Ye, Guobing Zhang, Xin Zhang Asian Journal of Surgery.2025; 48(10): 6375. CrossRef
Management and Outcomes of Adverse Events Following Immune Checkpoint Inhibitor Treatment in Patients with Hepatocellular Carcinoma Soon Kyu Lee, Bo Hyun Kim Journal of Digestive Cancer Research.2025; 13(1): 65. CrossRef
Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K/Akt/mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study Junli Zhang, Jiayi Guo, Ying Qian, Lianchen Yu, Junrao Ma, Biao Gu, Weichun Tang, Yi Li, Hongwei Li, Wenjuan Wu Cancer Reports.2025;[Epub] CrossRef
Role of cell cycle-related gene SAC3 domain containing 1 as a potential target of nitidine chloride in hepatocellular carcinoma progression Qing-Ling Huang, Sheng-Sheng Zhou, Jian-Di Li, Dan-Dan Xiong, Rong-Quan He, Zhi-Guang Huang, Lei Wang, Tian-Ming Tan, Yi-Wu Dang, Wei-Jia Mo, Zhen-Bo Feng, Gang Chen, Zhen-Dong Yang World Journal of Clinical Oncology.2025;[Epub] CrossRef
Navigating the complexities: challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma Yubo Jiang, Xiaofeng Dong, Yingying Zhang, Feiyan Su, Lei Zhao, Xuetao Shi, Jingtao Zhong Clinical and Experimental Medicine.2025;[Epub] CrossRef
AKR1C3 promotes bile acid production and contributes to the occurrence and development of liver cancer by upregulating HMG-CoA reductase Shenglong Wang, Gun Yang, Shanli Wu, Yaru Liu, Xiaosha Wen, Shang Chen, Dixian Luo, Quan Liu Oncologie.2025; 27(4): 615. CrossRef
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC Hee Sun Cho, Soon Kyu Lee, Ji Won Han, Jung Hyun Kwon, Soon Woo Nam, Jaejun Lee, Keungmo Yang, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi Frontiers in Immunology.2025;[Epub] CrossRef
Exosome-derived SLC12A2-DT promotes macrophage M2 polarization-mediated hepatocellular carcinoma progression Jingyi Zhou, Wencong Ma, Runkai Zhou, Di Ma, Chuan Liu, Fan Wang, Lin Yuan, Ling Xu, Chen Wang, Qi Li International Immunopharmacology.2025; 160: 114955. CrossRef
Unveiling the Therapeutic Potential of Targeting RRM2 in Hepatocellular Carcinoma: An Integrated In Silico and In Vitro Study Lobna Ibrahim, Rania Hassan Mohamed, Mahmoud M. Tolba, Sara M. Radwan, Nadia M. Hamdy, Mahmoud Elhefnawi Functional & Integrative Genomics.2025;[Epub] CrossRef
Monotropein Induced Ferroptosis to Alleviate the Progression of Hepatocellular Carcinoma via Regulating Nrf2/HO‐1/GPX4 Axis Bing Shi, Yan‐Ping Li, Zhuo Gan, Pan Chen The Kaohsiung Journal of Medical Sciences.2025;[Epub] CrossRef
Immunotherapy targeting liver cancer tumor-initiating cells: challenges, mechanisms, and emerging therapeutic horizons Yinying Chai, Tinghui Xu, Xin Chen, Bihua Chen, Xinghai Du, Zhezhong Zhang Frontiers in Immunology.2025;[Epub] CrossRef
TTLL4 mediates the PI3K/AKT/MDM2 pathway to promote hepatocellular carcinoma progression and predict patient prognosis Zeping He, Desheng Chen, Lei Li, Shanbao Li, Fangbin Song, Jinfeng Cai, Xueyan Guo, Yaohao Luo, Xinshuai Wang, Zeping Chen, Junming Xu APL Bioengineering.2025;[Epub] CrossRef
Innovative rapid pathological assessment technology for hepatocellular carcinoma following comprehensive treatment guided by indocyanine green fluorescence imaging Changcheng Tao, Huiru Yang, Nan Hu, Bo Zheng, Zhiyu Lu, Weiqi Rong, Fan Wu, Liming Wang, Dayong Cao, Jianxiong Wu, Zhanhan Tu, Xuan Meng, Haizhen Lu, Hongguang Wang Updates in Surgery.2025;[Epub] CrossRef
The Biological Role of LRPPRC in Human Cancers Jiaxin Tang, Jing Li, Shiyu Qin, Yu Xiao, Jiaxin Liu, Xian Chen, Yunyuan Zhang Cancer Control.2025;[Epub] CrossRef
The delaying effect of toripalimab on disease progression in patients with advanced hepatocellular carcinoma and changes in serum tumor markers Zhuo Yin, Yaomin Xiao, Jiangxue Gu, Pei Hu, Jiandu Jing, Xia Wang, Yao Liu, Shirong Yan World Journal of Surgical Oncology.2025;[Epub] CrossRef
Synthesis of Salidroside Derivatives at C4 Position of Benzene Ring and Its Effect on Hep3B Cell Viability Juntao Wang, Zhaoqi Yang, Zili Feng, Hongbo Zhao, Congxue Duan, Yunzhi Sheng, Pengfei Du, Wang Chen, Qingjuan Chen, Dong Xiao Chemical Biology & Drug Design.2025;[Epub] CrossRef
Global research trends in liver regeneration and immunomodulation: A perspective from bibliometric analysis Tongjie Xu, Dan Li Human Vaccines & Immunotherapeutics.2025;[Epub] CrossRef
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathway Xianwei Zhou, Chu Qiao, Xuehui Chu, Yajing Yang, Haoran Man, Jingxin Liu, Yunzheng Li, Zhu Xu, Huan Li, Xiaodong Shan, Zaowu Lian, Yanjun Lu, Weihong Wang, Decai Yu, Xitai Sun, Binghua Li Cellular Oncology.2025; 48(5): 1433. CrossRef
Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-β/SMADs pathway Zhengxin Jin, Zhengsen Jin, Zeyu Liu, Yongcheng Yin, Yuchen Zhang, Ying Zhang, Jianning Kang, Yuepeng Fang, Wei Jiang, Bin Ning Communications Biology.2025;[Epub] CrossRef
The role of HOXA1 in cancer and targeted therapy Jianshu Dong, Huimin Gong, Jian Li, Xinli Ma, Bilal Tayyab, Xia Xu Medical Oncology.2025;[Epub] CrossRef
Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma Hyewon Park, Sowon Park, Kena Park, Sun Young Yim, Ju-Seog Lee, Sung Hwan Lee ImmunoTargets and Therapy.2025; Volume 14: 787. CrossRef
Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway Yongfei He, Qiang Tao, Shutian Mo, Meifeng Chen, Jicai Wang, Hang Zhai, Shengjie Hong, Qiang Gao, Guangquan Zhang, Chuangye Han, Xianjie Shi Frontiers in Oncology.2025;[Epub] CrossRef
The use of durvalumab and tremelimumab after atezolizumab and bevacizumab in patients with hepatocellular carcinoma: case report and literature review Maen Abdelrahim, Abdullah Esmail Immunotherapy.2025; 17(11): 783. CrossRef
Evolution of approaches to the treatment of hepatocellular carcinoma N. A. Vlasova, V. I. Apanasevich, E. V. Yeliseeva, S. S. Startsev, V. I. Nevozhai Pacific Medical Journal.2025; (2): 24. CrossRef
Biomimetic “Trojan Horse” delivery of traditional Chinese medicine with immunogenic hybrid vesicles of bacterial outer membrane and tumor cell membrane for synergistic chemo-immunotherapy of liver cancers Zhaoyan Zhao, Lanxin Luo, Zhongting Wang, Bing Guo, Changjun Gao Materials Today Bio.2025; 34: 102251. CrossRef
Pro-Apoptosis Effects of Yangzheng-Xiaoji Capsules in Hepatocellular Carcinoma: Activation of the p53-Induced Apoptotic Pathway and Inhibition of the PI3K/Akt Pathway Ting-ting Zhou, Liu Li, Tian-hao Guo, Yu-han Wang, Dong-dong Sun, Jia-ni Tan, Cheng-tao Yu, Wei-xing Shen, Hai-bo Cheng Integrative Cancer Therapies.2025;[Epub] CrossRef
Heterogeneity in prognosis for early-stage hepatocellular carcinoma after hepatectomy: A multicenter analysis of 4,623 patients across five major staging systems Lan-Qing Yao, Hui-Xuan Fan, Fu-Jie Chen, Yu-Chen Li, Alfred Wei Chieh Kow, Yi-Fan Li, Ying-Jian Liang, Zi-Qiang Li, Yong-Yi Zeng, Qi-Xuan Zheng, Hong Wang, Ya-Hao Zhou, Ting-Hao Chen, Si-Yuan Wang, Hong-Wei Guo, Chao Li, Yong-Kang Diao, Jia-Hao Xu, Li-Hui European Journal of Surgical Oncology.2025; 51(10): 110383. CrossRef
De novo Drug Design and Repurposing to Suppress Liver Cancer via VEGF-R1 Mechanism: Comprehensive Molecular Docking, Molecular Dynamics Simulations and ADME Estimation Soykan Agar Medicinal Chemistry.2025; 21(6): 501. CrossRef
CCL5: An emerging key target and progress in the targeted therapy of hepatocellular carcinoma Xiaoli Liu, Jie Liang, Lizhen Zhao, Wei Li, Luoyang Wang, Xiao Wang, Yi Liu, Mengting Zhou, Xinqiang Li, Zhuoyu Jia, Meiying Song, Li Zhang, Yanyan Yang, Jinzhen Cai, Bei Zhang Molecular Immunology.2025; 187: 1. CrossRef
Nationwide Trends and Projections of Early Onset Gastrointestinal Cancers in China Tianyu Li, Chen Lin, Weibin Wang Cancers.2025; 17(18): 2954. CrossRef
Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma Chang Hun Lee, Yun Chae Lee, Seung Young Seo, Ga Ram You, Hoon Gil Jo, Sung Bum Cho, Eun Young Cho, In Hee Kim, Sung Kyu Choi, Jae Hyun Yoon BMC Cancer.2025;[Epub] CrossRef
Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular Carcinoma Shaobo Zhang, Jiabei Wang, Zebin Zhu, Peng Ji, Yanli Wang, Kun Cheng, Björn Nashan, Lianxin Liu, Shugeng Zhang Journal of Hepatocellular Carcinoma.2025; Volume 12: 2007. CrossRef
MED10 as a Novel Oncogenic Driver in HCC: Promoting Cell Cycle Progression and Proliferation Through RAF1 Activation Junhao Liu, Yongxue Lv, Kejun Liu, Zhengquan Li, Bendong Chen, Yang Bu Frontiers in Bioscience-Landmark.2025;[Epub] CrossRef
STOML2 inhibits sorafenib-induced ferroptosis in hepatocellular carcinoma via p-AKT signaling pathway Ruiqi Yin American Journal of Cancer Research.2025; 15(4): 1614. CrossRef
Combined Analysis of Protein Induced by Prothrombin Induced by Vitamin K Absence (PIVKA) and Alpha-L-Fucosidase (AFU) with Alpha-Fetoprotein (AFP) May Improve the Diagnostic Efficacy for Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Haisong Hou, Ruiqiang Weng, Liu Liang, Wendao Han International Journal of General Medicine.2025; Volume 18: 6031. CrossRef
Binding and ubiquitination-mediated degradation of ACKR3 by the novel Scutellarein derivative TBS6b potently suppresses hepatocellular carcinoma Xing Jiang, Ying Liang, Guotao Tang, Haiyan Quan, Lijun Ruan, Mengli Zhang, Zhijun Song, Min Ou, Zhien Tan, Na Lu, Fangfang Wu, Xiaonan Yang Bioorganic Chemistry.2025; 166: 109073. CrossRef
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway Shuai Liang, Zhongcheng Zhu, Yangshuo Tang, Shuhua Zhou, Moyan Xiao, Xuejun Gong, Ke Ye International Journal of Molecular Medicine.2025; 56(6): 1. CrossRef
Establishing a nomogram for post-hepatectomy liver failure prediction in hepatocellular carcinoma based on pre-operative and perioperative parameters Danni Wang, Qingmei Ma, Lei Zhang, Jinxia Hou, Zhemei Zhang, Jing Wu, Jingheng Zhang Frontiers in Medicine.2025;[Epub] CrossRef
Efficacy and safety of bifidobacterium triple viable capsules combined with entecavir in the treatment of Hepatitis B cirrhosis Rongquan Liu, Yun Ji, Jie Zhang Biomedical Papers.2025;[Epub] CrossRef
The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells Anjali Singh, Abhiram Natu, Flevia Anthony, Hemalatha Muthu, Bharat Khade, Duane T. Smoot, Hassan Ashktorab, Sanjay Gupta Clinical Epigenetics.2025;[Epub] CrossRef
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo Clinical Cancer Research.2025; 31(20): 4323. CrossRef
Ubiquitin-specific protease 24: a potential anti-cancer target Linxin Ye, Yufei Du, Yilin Mai, Tao Hu, Ping Chen Biochemical and Biophysical Research Communications.2025; 790: 152895. CrossRef
BACH1 promotes hepatocellular carcinoma progression by targeting PDP1 towards the PI3K-AKT-mTOR signaling activation Qiqi Bu, Xiaojing Qi, Qing Wang, Shujuan Liu, Shanshan Lin, Zhanhang Wang, Yiguo Zhang Bioorganic Chemistry.2025; 166: 109188. CrossRef
The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma Tianyu Ma, Feilong Zhao, Linmei Yao, Chuanchun Mao, Yuan Tian, Youyou Ma, Fanyun Kong, Ruyu Liu Clinical and Experimental Medicine.2025;[Epub] CrossRef
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents? Huidong Guo, Xiaojun Chen, Rong Li, Jianzhen Shen, Donghui Gan, Yue Yin, Hehui Zhang, Jiachen Xie, Longfei Xie, Yanquan Liu Journal of Hepatocellular Carcinoma.2025; Volume 12: 2513. CrossRef
Mechanisms of ferroptosis in primary hepatocellular carcinoma and progress of artificial intelligence-based predictive modeling in hepatocellular carcinoma Jiang-Feng Han, Zi-Yao Jia, Xiang Fan, Xue-Yan Zhao, Li-Ye Cheng, Yu-Xuan Xia, Xiao-Ran Ji, Wen-Qiao Zang World Journal of Gastroenterology.2025;[Epub] CrossRef
Functional liver imaging score derived from hepatobiliary-specific contrast-enhanced MRI: a study on agreement and correlation Hou-yun Xu, Xi-ping Yu, Xiao-chao Yu, Xuan Jin, Lu-ping Wang, Ji-bo Hu, Hong-jie Hu Insights into Imaging.2025;[Epub] CrossRef
ATPase Inhibitory Factor 1 Drives Mitochondrial Energy Metabolic Reprogramming to Promote HCC Vasculogenic Mimicry via the ESR1/miR-20a-3p/GNAZ Pathway Shilun Wu, Changyu Yao, Lu Fang, Yiwen Sun, Mingming Zhao, Jie Chen, Gaofei Hu, Zhe Zhao, Shusi Ding, Jing Xue, Xiaoyi Liu, Wenbing Sun, Jian Kong, Lemin Zheng Research.2025;[Epub] CrossRef
The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential Li Li, Xuhua Li, Fan Zhang Frontiers in Immunology.2025;[Epub] CrossRef
Global Contribution of Drug Use to Cirrhosis and Hepatocellular Carcinoma Worldwide From 1990 to 2021 and Projections to 2045 Jingru Han, Yang Zhao, Simeng Gao, Yan Zhang, Yida Wang, Jianfu Zhao INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2025;[Epub] CrossRef
Comparative study of 3D MR elastography and intravoxel incoherent motion for the evaluation of hepatocellular carcinoma grade Weimin Liu, Sidong Xie, Wenjie Tang, Ka Zhang Liver Research.2025; 9(4): 351. CrossRef
The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang BMC Cancer.2025;[Epub] CrossRef
Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration Maimaitiming Aimaiti, Dilimulati Maimaitituxun, Xiaokaiti Yilihaer, Talifujiang Kuerban, Junling Zhu, Mieradilijiang Ainiwaer, Zhiqiang Jia, Ainiwaerjiang Abudourousuli Journal of Hepatocellular Carcinoma.2025; Volume 12: 2693. CrossRef
Mitochondrial-associated PCD signature defines immune landscape, therapeutic sensitivity, and prognosis in hepatocellular carcinoma Xiao-qin Luo, Yi-min Cao, Yang Peng, Jing Dong, Zhi-yong Chen, Lu-shan Xiao, Wei-zhen Wang, Mei-ling Ai Discover Oncology.2025;[Epub] CrossRef
Identification and validation of prognostic markers for cuproptosis-related macrophage polarization genes in hepatocellular carcinoma Xin Deng, Jinying Cao, Yingying Liang, Bo Lyu, Ling Tong Discover Oncology.2025;[Epub] CrossRef
Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies Yang Tian, Yusheng Shi Journal of Biosciences and Medicines.2025; 13(02): 369. CrossRef
Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma Hye Yeon Chon The Korean Journal of Gastroenterology.2024; 83(2): 78. CrossRef
An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness Hao Peng, Kun Feng, Weilu Jia, Yunxin Li, Qingpeng Lv, Yewei Zhang Apoptosis.2024; 29(5-6): 898. CrossRef
Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma Ji Eun Han, Hyo Jung Cho Clinical and Molecular Hepatology.2024; 30(2): 160. CrossRef
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim Yonsei Medical Journal.2024; 65(7): 371. CrossRef
Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma Seung Kak Shin, Sooyeon Oh, Su‐Kyung Chun, Min‐Ji Ahn, Seung‐Min Lee, Kayun Kim, Hogyeong Kang, Jeongwoo Lee, Suk Pyo Shin, Jooho Lee, Young Kul Jung Journal of Gastroenterology and Hepatology.2024; 39(9): 1717. CrossRef
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco International Journal of Molecular Sciences.2024; 25(13): 7191. CrossRef
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235. CrossRef
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway? Ying Che, Xiaolong Lu, Xueting Wang, Zhien Liu, Liyang Guan, Xin Li, Zaixing Du, Hang Ren, Jihong Wang, Zunchun Zhou, Li Lv Cancer Cell International.2024;[Epub] CrossRef
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang PLOS ONE.2024; 19(8): e0307712. CrossRef
Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism Khaled Mohamed Mohamed Koriem World Journal of Gastroenterology.2024; 30(35): 3959. CrossRef
Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi Journal of Liver Cancer.2024; 24(2): 243. CrossRef
Preoperative C-reactive protein to albumin ratio may be a good prognostic marker in patients undergoing hepatectomy for hepatocellular carcinoma: a meta-analysis Shi Wang, Shengqian Xu, Jun Wang, Hailin Ye, Kai Zhang, Xiaopeng Fan, Xiaoya Xu Frontiers in Nutrition.2024;[Epub] CrossRef
Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung Liver Cancer.2024; : 1. CrossRef
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee Clinical and Molecular Hepatology.2024; 30(4): 807. CrossRef
CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1 Shuo Zhang, Gang Cao, Shuijie Shen, Yu Wu, Xiying Tan, Xiaoyan Jiang PeerJ.2024; 12: e18428. CrossRef
A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors Hui-min Yang, Xiang-ning Zhao, Xiao-ling Li, Xi Wang, Yu Pu, Dong-kai Wei, Zhe Li Biochemistry and Biophysics Reports.2024; 40: 101851. CrossRef
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma Jun-Ling Yang, Jie Yang, Rong-Fei Fang, Wen-Li Sai, Deng-Fu Yao, Min Yao World Journal of Hepatology.2024; 16(12): 1480. CrossRef
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung Frontiers in Immunology.2024;[Epub] CrossRef
CMTM6 promotes hepatocellular carcinoma invasion and metastasis and tumor-associated neutrophil immunoinfiltration through the Wnt/β-catenin pathway Panpan Kong, Huan Yang, Huifang Liu, Qing Tong, Mamumaimaitijiang-Abula Yi, Yong Zhao, Dong Yan European Journal of Medical Research.2024;[Epub] CrossRef
First
Prev
